Targeting Clostridioides difficile with microbiome-sparing, resistant-proof anti-toxins

Medicine & Life Sciences

1. Microbiota 100%
2. Infections 84%
3. Gastrointestinal Microbiome 81%
4. Anti-Bacterial Agents 77%
5. Microbial Drug Resistance 71%
6. Vancomycin 50%
7. Centers for Disease Control and Prevention (U.S.) 48%
8. Uridine Diphosphate Sugars 41%
9. rac GTP-Binding Proteins 38%
10. cdc42 GTP-Binding Protein 38%
11. Megacolon 36%
12. Transferases 35%
13. Glucosyltransferases 35%
14. Crystallography 34%
15. Epithelial Cells 33%
16. Bacterial Toxins 32%
17. Uridine Diphosphate 30%
18. Clostridium Infections 29%
19. Therapeutics 28%
20. Ileus 28%
21. Fatal Outcome 28%
22. Static Electricity 27%
23. Isotopes 25%
24. Colitis 24%
25. Hypotension 22%
26. Lead 21%
27. Health Care Costs 21%
28. Shock 20%
29. Immunity 19%
30. Vaccines 17%
31. Kinetics 17%
32. Fecal Microbiota Transplantation 15%
33. Guidelines 15%
34. Morbidity 13%
35. Threonine 12%
36. GTP-Binding Proteins 11%
37. Pressure 7%
38. Antibodies 6%
39. Mortality 5%